最少侵入性与跨导管大动脉置换:更新的元分析和系统审查
Adham Ahmed1, Ahmed K Awad2, Kathryn S Varghese1
1City University of New York School of Medicine, NY, USA.
Innovations (Philadelphia, Pa.)
|September 2, 2023
概括
与跨导管大动脉置换 (TAVR) 相比,微创手术大动脉置换 (mini-SAVR) 显示出较低的死亡率和较少的并发症,如准膜泄漏和起器需求. 然而,TAVR与急性损伤的减少有关.
科学领域:
- 心血管外科心血管外科
- 干预心脏病学 干预心脏病学
- 医疗技术评估 医疗技术评估
背景情况:
- 过导管大动脉置换 (TAVR) 是外科手术对大动脉置换的一种替代方案.
- 微创手术大动脉置换 (迷你SAVR) 技术,包括迷你胸切除术和迷你胸切除术,正在获得吸引力.
- 需要进一步研究TAVR和迷你SAVR的比较疗效.
研究的目的:
- 进行双对分析,比较TAVR和迷你SAVR的疗效.
- 评估TAVR和迷你SAVR之间的关键临床结果和程序安全性.
主要方法:
- 在医疗数据库的全面搜索中,发现了12项比较TAVR与迷你SAVR模式的研究.
- 使用通用逆方差方法进行了随机效应元分析.
- 主要结局包括30天和中期死亡率,中风,急性损伤 (AKI),膜漏洞 (PVL),永久心脏起器 (PPM) 植入,心房动和门压力梯度.
主要成果:
- 与TAVR相比,迷你SAVR的30天死亡率 (RR=0.63) 和中期死亡率 (HR=0.76) 显著降低.
- 迷你SAVR显示了30天PVL (RR=0.07) 和新的PPM (RR=0.25) 的降低率.
- TAVR与较低的30天AKI (RR=1.67) 和较低的干预后平均梯度 (MD=1.65) 相关.
结论:
- 与TAVR相比,Mini-SAVR提供了对死亡率,PVL和心脏起器要求的保护性益处.
- 塔弗显示在减少30天AKI方面具有优势.
- 需要进一步的随机试验,以最终比较迷你SAVR和TAVR的疗效.
相关概念视频
Mitral Stenosis III: Medical Management
12
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12
Aortic Regurgitation III: Medical Management
25
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
25
Mitral Regurgitation III: Medical Management
18
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
18
Mitral Valve Prolapse II: Assessment and Management
21
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
21


